References
-
1) Translocator protein 18 kDa regulates retinal neuron apoptosis and pyroptosis in glaucoma.
-
2) Pathologically high intraocular pressure induces mitochondrial dysfunction through Drp1 and leads to retinal ganglion cell PANoptosis in glaucoma.
-
3) Ginsenoside Rd promotes omentin secretion in adipose through TBK1-AMPK to improve mitochondrial biogenesis via WNT5A/Ca2+ pathways in heart failure.
-
4) Ultraviolet B radiation-induced JPH203-loaded keratinocyte extracellular vesicles exert etiological interventions for psoriasis therapy.
-
5) Metformin-based carbon dots based on biguanide functional groups for simultaneous chelation of copper ions and inhibitable colorectal cancer therapy.
-
6) Bioinspired nanovehicle of furoxans-oxaliplatin improves tumoral distribution for chemo-radiotherapy.
-
7) Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma.
-
8) Mesenchymal stem cell exosomes as nanotherapeutics for dry age-related macular degeneration.
-
9) A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration.
-
10) cRGD-targeted heparin nanoparticles for effective dual drug treatment of cisplatin-resistant ovarian cancer.
-
11) ADAMTS7-Mediated Complement Factor H Degradation Potentiates Complement Activation to Contributing to Renal Injuries.
-
12) Isothiazolinone dysregulates the pattern of miRNA secretion: Endocrine implications for neurogenesis.
-
13) Environmental endocrine disruptor Bisphenol A induces metabolic derailment and obesity via upregulating IL-17A in adipocytes.
-
14) Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression.
-
15) An intravitreal-injectable hydrogel depot doped borneol-decorated dual-drug-coloaded microemulsions for long-lasting retina delivery and synergistic therapy of wAMD.